| abstract |
The present invention provides compositions and methods of using stem cells similar to embryonic originating from a placenta after delivery with cells of conventional compositions of cord blood or other stem cells or progenitor cells. Embryonic-like stem cells can be used alone or in a mixture with other populations of stem cells. In accordance with the present invention, embryonic-like stem cells may be mixed with other populations of stem cells, which include but are not limited to umbilical cord blood cells, fetal and neonatal hematopoietic stem cells and other progenitor cells, cells Human mother and progenitor cells derived from bone marrow. Embryonic stem cells and mixed populations of embryonic stem cells and stem cells have a multitude of uses and applications, including but not limited to, therapeutic use for transplantation and treatment and prevention of conditions , and uses in diagnosis and research. |